Viewing Study NCT06422533


Ignite Creation Date: 2025-12-25 @ 3:01 AM
Ignite Modification Date: 2026-01-08 @ 1:05 PM
Study NCT ID: NCT06422533
Status: RECRUITING
Last Update Posted: 2024-06-04
First Post: 2024-04-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia in Hemato-oncological Patients
Sponsor: Instituto Nacional de Cancerologia de Mexico
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module